RACHEL DAVIS: Open Payments
NPI 1174156962 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 6 payments from 4 companies in 2025. Trend: 2023 $32 · 2024 $161 · 2025 $489
Food & beverage: $390Education: $99
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $264 |
| SEAGEN INC. | 1 | $99 |
| Stemline Therapeutics Inc. | 1 | $78 |
| Incyte Corporation | 2 | $49 |
Products named: INGREZZA, ELZONRIS, JAKAFI.
Industry payments across ID — which companies pay providers there.
